These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 1361264)
1. Proliferating cell nuclear antigen immunostaining of the endothelial cells in lung transplantation. Barberis M; Harari S Transplant Proc; 1992 Dec; 24(6):2667-9. PubMed ID: 1361264 [No Abstract] [Full Text] [Related]
2. Transplant arterial vasculopathy: evidence for a dual pattern of endothelial injury and the source of smooth muscle cells in lesions of intimal hyperplasia. Aziz S; McDonald TO; Gohra H J Heart Lung Transplant; 1995; 14(6 Pt 2):S123-36. PubMed ID: 8719474 [TBL] [Abstract][Full Text] [Related]
3. Which is the target vessel of lung rejection? A primate heart-lung transplantation study. Kawauchi M; Matsumoto J; Takeda M; Nakajima J; Furuse A; Oka T; Yoshitake T Transplant Proc; 1994 Aug; 26(4):2338-9. PubMed ID: 8066766 [No Abstract] [Full Text] [Related]
5. The prognostic significance of intimal proliferation in cardiac allograft vasculopathy: a paradigm shift. Mehra MR; Ventura HO; Stapleton DD; Smart FW J Heart Lung Transplant; 1995; 14(6 Pt 2):S207-11. PubMed ID: 8719487 [No Abstract] [Full Text] [Related]
6. Distinct expression of cell-cell and cell-matrix adhesion molecules on endothelial cells in human heart and lung transplants. Steinhoff G; Behrend M; Richter N; Schlitt HJ; Cremer J; Haverich A J Heart Lung Transplant; 1995; 14(6 Pt 1):1145-55. PubMed ID: 8719462 [TBL] [Abstract][Full Text] [Related]
7. Short-term survivors of pediatric heart transplantation: an autopsy study of their pulmonary vascular disease. Collins MH; Darragh RK; Caldwell RL; Turrentine MW; Brown JW J Heart Lung Transplant; 1995; 14(6 Pt 1):1116-25. PubMed ID: 8719459 [TBL] [Abstract][Full Text] [Related]
8. Cytokine-mediated fibronectin production and transendothelial migration of lymphocytes in the mechanism of cardiac allograft vascular disease: efficacy of novel therapeutic approaches. Rabinovitch M; Molossi S; Clausell N J Heart Lung Transplant; 1995; 14(6 Pt 2):S116-23. PubMed ID: 8719473 [No Abstract] [Full Text] [Related]
9. [Causes of subintimal hyperplasia in organ transplantation]. Lepidi S; Schmitz-Rixen T; Berwanger C; van Swyndregt AD; Addicks K Vasa Suppl; 1992; 35():120-2. PubMed ID: 1481013 [No Abstract] [Full Text] [Related]
10. The pathogenesis of graft vascular disease: implications of vascular remodeling. Gibbons GH J Heart Lung Transplant; 1995; 14(6 Pt 2):S149-58. PubMed ID: 8719477 [No Abstract] [Full Text] [Related]
11. Which are the target vessels of xeno- and allo-lung rejection?--a primate single lung transplantation study. Kawauchi M; Takeda M; Matsumoto J; Nakajima J; Furuse A; Oka T; Yoshitake T Transplant Proc; 1996 Jun; 28(3):1416-7. PubMed ID: 8658719 [No Abstract] [Full Text] [Related]
12. Clinical-pathologic features of humoral rejection in cardiac allografts: a study in 81 consecutive patients. Lones MA; Czer LS; Trento A; Harasty D; Miller JM; Fishbein MC J Heart Lung Transplant; 1995; 14(1 Pt 1):151-62. PubMed ID: 7727464 [TBL] [Abstract][Full Text] [Related]
13. [Structural changes in the portal vein wall in liver cirrhosis. Studies with the unfolded venous tube]. Krenz G; Meyer WW Frankf Z Pathol; 1966; 75(5):375-84. PubMed ID: 16300331 [No Abstract] [Full Text] [Related]
14. Proliferating cell nuclear antigen expression in endomyocardial biopsies is predictive of progression of rejection and the need for enhanced immunosuppression. Salom RN; Maguire JA; Esmore D; Hancock WW Transplant Proc; 1993 Oct; 25(5):2894-5. PubMed ID: 8105588 [No Abstract] [Full Text] [Related]